+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Adjudication Service Market by Service Type, Trial Phase, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Clinical Trial Adjudication Service Market by Service Type, Trial Phase, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

Clinical Trial Adjudication Service Market by Service Type, Trial Phase, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090465
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial adjudication service market is evolving rapidly, driven by increasing complexity in trial designs, tighter regulatory oversight, and the integration of new digital solutions. Senior decision-makers are prioritizing robust adjudication processes to ensure unbiased evaluation, faster timelines, and improved data integrity across therapeutic portfolios.

Market Snapshot of the Clinical Trial Adjudication Service Market

The Clinical Trial Adjudication Service Market grew from USD 498.30 million in 2024 to USD 539.51 million in 2025. It is expected to continue growing at a CAGR of 8.44%, reaching USD 810.57 million by 2030. Expansion is underpinned by rising demand for independent, expert-driven review processes that elevate trial credibility and accelerate regulatory submissions. Sponsors, contract research organizations, and biotechnology firms are increasingly seeking partners with advanced technology capabilities, operational scale, and deep therapeutic expertise.

Scope & Segmentation

  • Service Types: Dossier preparation and creation, endpoint adjudication, event adjudication, and invoice submission functions streamline sponsor workflows and help meet regulatory documentation needs.
  • Trial Phases: Supports Phase I through Phase IV trials, covering quick-turn safety reviews for early-stage studies to long-term safety monitoring in post-approval settings.
  • Therapeutic Areas: Services cater to trials in cardiovascular diseases, hematology, infectious diseases, nephrology, neurological disorders, oncology, and respiratory conditions.
  • End Users: Academic and research institutions, contract research organizations, and pharmaceutical and biotechnology companies utilize adjudication services for operational scale and compliance.
  • Geographic Reach: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, Saudi Arabia, UAE, South Africa, and more); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and others).
  • Technology Adoption: Industry leverages electronic adjudication platforms, AI and machine learning for event pre-screening, cloud-based workflows, and risk-based monitoring approaches to enhance efficiency.
  • Competitive Landscape: Key companies include Advarra, Caidya, Charles River Laboratories, Clario, Ethical GmbH, Fortrea, ICON, IQVIA, Medpace, Parexel, SGS, Syneos, Thermo Fisher Scientific, and others.

Key Takeaways

  • Technological advancements, such as AI-driven event review platforms, are reducing manual workloads and streamlining adjudication cycles.
  • Service offerings are diversifying, with providers launching tailored options for both high-volume pivotal trials and specialized, adaptive studies.
  • Regulatory expectations are pushing sponsors to adopt transparent, risk-based monitoring and to strengthen endpoint consistency across global studies.
  • Demand is rising for scalable digital infrastructure and flexible charters to address the challenges of multicenter and decentralized trials.
  • Strategic partnerships with academic networks and patient advocacy groups are supporting more nuanced, patient-centric adjudication approaches.
  • Regional market nuances require localized expertise as regulatory environments and trial volumes expand worldwide.

Tariff Impact

The introduction of new US tariffs in 2025 has placed upward pressure on operational costs for clinical trial adjudication service providers. Increased expenses have been observed due to tariffs on imported server hardware and specialized software, impacting data storage and secure workflow platforms. Service agreements are being repriced, and supply chain diversification—including alternative vendors and geographically dispersed data centers—is mitigating risk. Sponsors are responding by exploring hybrid outsourcing models to balance quality, compliance, and cost amid evolving trade policies.

Methodology & Data Sources

This report employs a robust blend of rigorous secondary research—including industry guidelines, regulatory documents, corporate filings, and white papers—and in-depth primary interviews with key market stakeholders. Analyses are reinforced by quantitative assessments of service adoption patterns, volume trends, and pricing, with statistical validation to ensure accuracy and credibility.

Why This Report Matters

  • Enables C-level leaders and operational strategists to anticipate regulatory shifts, streamline adjudication processes, and drive greater efficiency across trial portfolios.
  • Offers comprehensive intelligence on regional market drivers, technology integration, and competitive positioning critical for optimizing clinical trial investments.
  • Guides informed decision-making by identifying partnership and innovation opportunities aligned with evolving global requirements.

Conclusion

The clinical trial adjudication service market is entering a period of digital transformation and operational refinement. Providers and sponsors that embrace technology, partnership, and compliance will improve performance and sustain competitive positioning in an increasingly regulated landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Trial Adjudication Service Market, by Service Type
8.1. Introduction
8.2. Dossier Preparation & Creation
8.3. Endpoint Adjudication
8.4. Event Adjudication
8.5. Invoice Submission
9. Clinical Trial Adjudication Service Market, by Trial Phase
9.1. Introduction
9.2. Phase I Trials
9.3. Phase II Trials
9.4. Phase III Trials
9.5. Phase IV Trials
10. Clinical Trial Adjudication Service Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Hematology
10.4. Infectious Diseases
10.5. Nephrology
10.6. Neurological Disorders
10.7. Oncology
10.8. Respiratory Diseases
11. Clinical Trial Adjudication Service Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Clinical Trial Adjudication Service Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Clinical Trial Adjudication Service Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Clinical Trial Adjudication Service Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Advarra, Inc.
15.3.2. Caidya Inc.
15.3.3. Charles River Laboratories
15.3.4. Clario
15.3.5. Emerald ROW Newco Pte Ltd
15.3.6. Ethical GmbH
15.3.7. Fortrea, Inc
15.3.8. ICON plc
15.3.9. IQVIA HOLDINGS INC.
15.3.10. Judi by AG Mednet
15.3.11. LABCORP HOLDINGS INC
15.3.12. Lindus Health Limited
15.3.13. Medidata Solutions, Inc. by Dassault Systèmes S.E.
15.3.14. Medpace Holdings, Inc.
15.3.15. Parexel International Corporation
15.3.16. Perceptive Informatics LLC
15.3.17. Premier Research International LLC
15.3.18. SGS S.A.
15.3.19. Sitero, LLC
15.3.20. Syneos Health, Inc.
15.3.21. Thermo Fisher Scientific Inc.
15.3.22. Voiant LLC.
15.3.23. WCG Clinical, Inc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CLINICAL TRIAL ADJUDICATION SERVICE MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL ADJUDICATION SERVICE MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL ADJUDICATION SERVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL TRIAL ADJUDICATION SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CLINICAL TRIAL ADJUDICATION SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CLINICAL TRIAL ADJUDICATION SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY DOSSIER PREPARATION & CREATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY ENDPOINT ADJUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY EVENT ADJUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY INVOICE SUBMISSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY PHASE I TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY PHASE II TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY PHASE III TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY PHASE IV TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. CANADA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 40. CANADA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 41. CANADA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 45. MEXICO CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED KINGDOM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED KINGDOM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 61. UNITED KINGDOM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. GERMANY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 66. GERMANY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. FRANCE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 68. FRANCE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 69. FRANCE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 70. FRANCE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. RUSSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 72. RUSSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 73. RUSSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. RUSSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ITALY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 76. ITALY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 77. ITALY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 78. ITALY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. SPAIN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 80. SPAIN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 81. SPAIN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. SPAIN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED ARAB EMIRATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED ARAB EMIRATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 85. UNITED ARAB EMIRATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 86. UNITED ARAB EMIRATES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. SOUTH AFRICA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. DENMARK CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 96. DENMARK CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 97. DENMARK CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. DENMARK CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. QATAR CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 104. QATAR CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 105. QATAR CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 106. QATAR CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. FINLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. FINLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 109. FINLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 110. FINLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. SWEDEN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 112. SWEDEN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 113. SWEDEN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. SWEDEN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. EGYPT CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 120. EGYPT CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 121. EGYPT CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 122. EGYPT CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. TURKEY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. TURKEY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 125. TURKEY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 126. TURKEY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. NORWAY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 132. NORWAY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 133. NORWAY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 134. NORWAY CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. POLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 136. POLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 137. POLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 138. POLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. CHINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 150. CHINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 151. CHINA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. INDIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 153. INDIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 154. INDIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 155. INDIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. THAILAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. THAILAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 174. THAILAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 175. THAILAND CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN CLINICAL TRIAL ADJUDICATION SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. CLINICAL TRIAL ADJUDICATION SERVICE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 197. CLINICAL TRIAL ADJUDICATION SERVICE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Trial Adjudication Service market report include:
  • Advarra, Inc.
  • Caidya Inc.
  • Charles River Laboratories
  • Clario
  • Emerald ROW Newco Pte Ltd
  • Ethical GmbH
  • Fortrea, Inc
  • ICON plc
  • IQVIA HOLDINGS INC.
  • Judi by AG Mednet
  • LABCORP HOLDINGS INC
  • Lindus Health Limited
  • Medidata Solutions, Inc. by Dassault Systèmes S.E.
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Perceptive Informatics LLC
  • Premier Research International LLC
  • SGS S.A.
  • Sitero, LLC
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • Voiant LLC.
  • WCG Clinical, Inc

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 539.51 Million
Forecasted Market Value ( USD ) by 2030 $ 810.57 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033 - Product Image

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033

  • Report
  • 220 Pages
  • Global
From
Clinical Trials Market in the US 2025-2029 - Product Image

Clinical Trials Market in the US 2025-2029

  • Report
  • 166 Pages
  • United States
From
North America Clinical Trials Market Size and Forecast Report 2025-2033 - Product Image

North America Clinical Trials Market Size and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • North America
From
KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 - Product Image

KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025

  • Report
  • 75 Pages
  • Global
From
Clinical Trial Services Market by Service Type, Trial Phase, Therapeutic Areas, End User - Global Forecast to 2030 - Product Image

Clinical Trial Services Market by Service Type, Trial Phase, Therapeutic Areas, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.